RFA
DPLO

Reilly Financial Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Reilly Financial Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-500
Closed -$14K – 1022
2016
Q1 		$14K Buy
+500
New +$14.7K ﹤0.01% 685

Other funds holding DPLO

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Reilly Financial Advisors's DPLO Position: Q2 2016 in Review

Reilly Financial Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2016, closing a stake of 500 shares — an estimated $14K sold.

Reilly Financial Advisors first reported a position in DPLO in Q1 2016 and held it in 1 quarter. The position peaked at $14K in Q1 2016. 166 funds tracked by Wall St. Rank hold DPLO as of Q2 2016.

  • Reilly Financial Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2016 after selling out during the quarter.
  • Reilly Financial Advisors sold 500 DIPLOMAT PHARMACY, INC. shares in Q2 2016, an estimated $14K.
  • Reilly Financial Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2016 and held it in 1 quarter.
  • Reilly Financial Advisors's DIPLOMAT PHARMACY, INC. position peaked at $14K in Q1 2016.
  • 166 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2016.

Based on Reilly Financial Advisors's 13F filing for Q2 2016, filed 3 Aug 2016.